Asset Medical is TGA APPROVED! Our products will proudly serve to protect the lives of many Australians from infections.

Asset Medical Design needle free valve product range has been approved by Australian Department of Health TGA in November 2018.

Welcome to the family, SwabArt® Disinfection Cap! SwabArt® is available in strips of 10 pieces.

Asset is proud of announcing its brand new product SwabArt® Disinfection Cap which is going to be launched in Q1 2019. SwabArt® Disinfection Cap for Swabbable Needle-free Valves is a single-use disinfection product impregnated with a high liquid absorbent sponge saturated with 70% Isopropyl Alcohol (IPA) and 70% Isopropyl Alcohol (IPA)+2%Chlorhexidine that protects patients from infection.

Female Entrepreneur of the Year award goes to Asset Medical

KOSGEB has granted an award to Asset Medical Design Inc. in 2012 in the contest where SMEs, which have demonstrated a stable growth and possess a high market share, create added value with the export, efficiency level and employment rates.

Pera Capital has acquired 45 percent of the shares of Asset Medical Design Inc.

Pera Capital has acquired 45 percent of the shares of Asset Medical Design Inc., a manufacturer medical company specialized in IV infusion products that contain needle free valves. Pera Capital is an independent, private equity fund focusing on mid-sized enterprises in Turkey. Pera Capital's corporate investors include European Bank for Reconstruction and Development (EBRD), European Investment Funds (EIF), Caisse des Depots (CDC), and Sarona Asset Management, and prominent European family investment offices.

Asset Medical Design Inc. is one of the 100 fastest growing companies in Turkey

Asset Medical Design Inc. was deemed worthy of the "Turkey 100" award as one of the 100 fastest growing companies in Turkey Given by TOBB in 2017.